Delivery Order SPE2DR25D3201-SPE2DR26FT6QF

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 9, 2026, with a ceiling value of $25,637.70 for OCREVUS 300 mg/10 mL vial (10 mL).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 3, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Ocrevus 300 mg/10 ml vial 10 ml, with a ceiling value of $76,913.10. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), a global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026, which enables supply of a comprehensive range of pharmaceutical products and medical supplies...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 ml vials with a ceiling value of $25,332.96 under a firm fixed-price contract. The award was issued on December 22, 2025, with an ultimate completion date of January 14, 2026, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This non-set-aside delivery order represents a competitive award to a major pharmaceutical distributor that serves as a...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ocrevus 300 mg/10 mL vials with a ceiling value of $120,192.80 and a firm fixed price structure. The order is scheduled for completion by October 14, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...

The Defense Logistics Agency awarded a $25,332.96 delivery order to AmerisourceBergen Drug Corp for OCREVUS 300 mg/10 mL vials on December 22, 2025, with completion targeted for January 14, 2026. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...

The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Ocrevus 300 mg/10 ml vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $50,665.92 and an ultimate completion date of December 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...

The Defense Logistics Agency awarded a delivery order valued at $51,275.40 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on January 22, 2026, with an ultimate completion date of February 12, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded transaction within the federal pharmaceutical procurement process. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Ocrevus 300 mg/10 mL vials with a ceiling value of $72,115.74 and a firm fixed price structure. The contract is classified as a child order under a larger indefinite delivery vehicle and carries an ultimate completion date of September 11, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...

The Defense Logistics Agency awarded a $120,192.80 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price contract with an ultimate completion date of August 14, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical...

The Defense Logistics Agency awarded a $76,913.10 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price contract with a completion date of February 23, 2026, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...